Analysis on the Availability and Affordability of Cardiovascular Disease (CVD) Medicines
Overview
WDI conducted a preliminary mapping of the global supply for CVD medications to develop policy recommendations for the GlobalHEARTS Initiative. Developed by the Centers for Disease Control and World Health Organization, the initiative works to promote research to examine the barriers affecting availability and access to CVD pharmaceuticals in low- and middle-income countries. WDI also analyzed a host of country Essential Medicines Lists for CVD medication inclusion.